Clinical Trials Browser

Terminated × Interventional × Advanced Malignant Solid Neoplasm × Clear all

NCT04171219 2025-05-16

Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers

Phase 2 Terminated

31 enrolled 15 charts

Other solid neoplasm

Advanced Malignant Solid Neoplasm

NCT04552704 2023-08-02

CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study

Phase 1/2 Terminated

3 enrolled 12 charts

Other solid neoplasm

Advanced Malignant Solid Neoplasm